Background/AIM: STIM1 is as an essential component in store operated Ca 2+ entry. However give the paucity of information on the role of STIM1 in kidney, the aim was to study the function of STIM1 in the medulla of the kidney. Methods: we crossed a Ksp-cre mouse with another mouse containing two loxP sites flanking Exon 6 of STIM1. The Ksp-cre mouse is based upon the Ksp-cadherin gene promoter which expresses cre recombinase in developing nephrons, collecting ducts (SD) and thick ascending limbs (TAL) of the loop of Henle. Results: The offspring of these mice are viable without gross morphological changes, however, we noticed that the STIM1 Ksp-cre knockout mice produced more urine compared to control. To examine this more carefully, we fed mice low (LP) and high protein (HP) diets respectively. When mice were fed HP diet STIM1 ko mice had significantly increased urinary volume and lower specific gravity compared to wt mice. In STIM1 ko mice fed HP diet urine creatinine and urea were significantly lower compared to wt mice fed HP diet, however the fractional excretion was the same. Conclusion: These data support the idea that STIM1 ko mice have impaired urinary concentrating ability when challenged with HP diet is most likely caused by impaired Ca 2+ -dependent signal transduction through the vasopressin receptor cascade.
Introduction
STIM1 described initially as tumor suppressor gene [1] serves as Ca 2+ sensing protein [2] . STIM1 is a transmembrane protein with its Ca +2 sensing domain facing the lumen of the ER. When ER Ca 2+ stores are depleted, STIM1 senses that ER Ca +2 is low and translocates to the plasma membrane [2] . At the plasma membrane STIM1 activates the so called 'calcium release-activated Ca 2+ current, CRAC, via Orai1 and perhaps other Ca 2+ channels [3] [4] [5] . The Ca 2+ that enters the cell via SOCE is pumped into the ER lumen via the SERCA, the ER Ca 2+ pump [6] . Ca 2+ release plays a role in signal transduction in the kidney. For example, it is well known that AVP binds to the V2R in the basolateral membrane and induces the insertion of AQP2 water channels into the apical membrane of the collecting duct [7] . The insertion of AQP2 water channels increases collecting duct water permeability and the absorption of water from the final urine back into the body. This phenomenon is essential for water conservation [8] . How AVP induces the insertion of AQP2 into the plasma membrane has been intensely investigated. AVP activates the adenylate cyclase (AC) enzyme increasing intracellular cAMP levels, and the phosphorylation of AQP2 and in addition increases intracellular Ca 2+ [9] . The latter is thought to be mediated via the release of ER Ca 2+ via the ryanodine-receptor [10] . AVP stimulation results in oscillations in cytosolic Ca 2+ which also occurs via the rapid and transient movement of Ca 2+ out of the ER via ryanodine receptor. Inhibition of the increase in intracellular Ca 2+ induced by AVP prevents AQP2 trafficking even in the presence of elevated intracellular cAMP levels pointing out that ER release and subsequent SOCE has an essential role for water conservation [10] .
We showed in MDCK cells, a model renal epithelial cell line, that ATP operating through purinergic receptor activation and thereby increasing IP 3 causing release of Ca 2+ by the ER via the IP 3 R, and depleting ER Ca +2 causes the translocation of STIM1 to the plasma membrane activating SOCE [11] [12] [13] . Interestingly, we observed that the translocation was modulated by 100 kd C-terminal cleavage fragment (P100) of polycystin 1 (PC-1) [11] .
PC-1 is a large membrane protein with 11 putative transmembrane regions and a short cytoplasmic C-terminus [14] . PC-1 by itself has no channel activity, however, it binds to PC-2 to form a complex resulting in transmembrane Ca 2+ movement via PC-2 [15] . PC-2 is a member of the TRP family (PPC2) [16] . Mutations in either PC-1 or 2 cause adult onset polycystic kidney disease which is the most common dominant genetic disorder in humans [17] . ADPKD is characterized by the progressive, enlargement of multiple renal cysts leading to a decline in renal function and culminating in renal failure in 50% of patients [18] . PC-1 is known to have several cleavage sites resulting in multiple fragments [19] . For example cleavage of a small C-terminal fragment allows it to be translocated to the nucleus where it functions in nuclear signal transduction [20] . Cleavage at the GPS site generates N-and C-terminal fragments. Although the precise function of GPS cleavage is unknown, mutations at this site cause polycystic kidney disease particularly in animal models [21] . Thus, cleavage at GPS site is clearly important for normal function in postnatal period. We showed that the P100 fragment of PC-1 binds to STIM1 and to the IP3R and sequesters STIM1 in the ER [11] . When the cells are stimulated by ATP which causes an increase in intracellular through ER Ca 2+ release, STIM1 remains in the ER, whereas in the absence of P100, PC-1 STIM1 translocates to the plasma membrane where it activates SOCE. The overall effect of P100 binding is to reduce the cellular response to signal transduction cascades that increase intracellular Ca 2+ and to reduce the amount of STIM1 that resides at the plasma membrane. It is becoming increasingly clear that an excess of STIM1 at the plasma membrane is associated with increase cell proliferation in several cancers [22] . Thus, P100 may be protective to the kidney by reducing STIM1 at the plasma membrane.
In view of the potential role of STIM1 as an essential component in SOCE and the paucity of information on the role of STIM1 in kidney, we crossed a Ksp-cre mouse [23] with another mouse containing two loxP sites flanking Exon 6 of STIM1. The Ksp-cre mouse is based upon the Ksp-cadherin gene promoter which expresses cre recombinase in developing nephrons, collecting ducts (SD) and thick ascending limbs (TAL) of the loop of Henle [24] . The STIM1-loxP mouse was provided to us by Paul Worley at JHU. The offspring of these mice are viable but show a defect in their ability to concentrate urine.
Materials and Methods

Stim1
fl/fl Ksp-cre mouse STIM1 knockout (ko) mouse was created and provided to us by Paul Worley in the Department of Neuroscience at JHU. The mouse has two loxP sites flanking Exon 6 (see Fig. 1 ). To focus on the kidney, we obtained the Ksp-cre mouse which is based upon the Ksp-cadherin gene promoter which expresses cre recombinase in developing nephrons, collecting ducts and thick ascending limbs of the loop of Henle and distal tubules [24, 25] . Stim1 fl/fl Ksp-cre mouse was obtained from crossing STIM1 knockout mouse and Kspcre mouse. Mice were genotyped for the Ksp-cre using the primers and protocol from Jackson Labs.
Animals, treatments, and diets
All animal use complied with the guiding principles of the Johns Hopkins University Institutional Animal Care and Use Committee, and the protocols for this work were approved by this committee. All mice had unlimited access to water and were fed a normal laboratory chow from weaning. Standard laboratory chow has 20% protein. We fed mice high-and low-protein diets 4% or 40% protein for one week according to the procedure developed by Fenton and colleagues [26] .
Urine and serum parameters
Urinary creatinine, urea, calcium, specific gravity as well as BUN, serum creatinine, albumin and calcium were measured by Johns Hopkins Comparative Medicine Laboratory. Fractional excretion of urea (FEUr) was calculated using the following formula: (UUr*SCr)/(UCr*BUN), where UUr is urinary urea, SCr is serum creatinine, UCr is urinary creatinine and BUN is blood urea nitrogen. Creatinine clearance (CrCl) was calculated using the following formula: UCr*V/SCr/1440, where UUr is urinary urea, V is 24h urine volume, SCr is serum creatinine and 1440 represents minutes in a 24h period. Urea clearance (UrCl) was calculated using the following formula: UUr*V/BUN/1440, where UUr is urinary urea, V is 24h urine volume, BUN is blood urea nitrogen and 1440 represents minutes in a 24h period. Fractional calcium excretion was calculated using the following formula: (UCa*SCr)/(SCa*UCr)*100, where UCa is urinary calcium, SCr is serum creatinine, SCa is serum calcium and UCr is urinary creatinine.
Kidney histology
Kidneys were quickly excised, stripped of the renal capsule, sagitally sectioned, and fixed in 4% paraformaldehyde in 0.1 mol/L phosphate buffer for 24 hours, and then paraffin embedded and sectioned. Sections were deparaffinized with xylene and rehydrated with descending ethanol into PBS, then stained with Von Kosa, hematoxylin and eosin. Sections were examined by a renal pathologist blinded to animal group and were graded for the presence of nephrocalcinosis in the medulla. A total of three to four histologic sections were analyzed for each mouse. Quantification of nephrocalcinosis was based on the following grading schema: 0 = no calcium, 1 = 1-4 calcium deposits, 2 = 5-8 calcium deposits, 3 = greater than 8 calcium deposits.
Statistical analysis Data are expressed as mean ± SE (N = number of animals). Comparisons between Stim1
fl/fl Ksp-cre and wild-type mice were assessed by using unpaired Student t test, and P values less than 0.05 were considered significant.
Results
STIM1 flox genotyping
The Lox P site insertion in Stim1 was detected with primers that revealed both the presence of a floxed allele in each mouse and the hetero-or homozygosity (Fig. 1) .
Urine volume and specific gravity STIM1 ko and wt mice were fed a defined normal protein (NP) diet (20% protein), low protein (LP) diet (4% protein) or high protein (HP) diet (40% protein). Urine volume was similar in STIM1 ko mice when compared to wild type (wt) mice fed either NP or LP diet (Fig.  2) . When mice were fed HP diet STIM1 ko mice had significantly increased urinary volume compared to wt mice ( Fig. 2A) . Next we measured urine specific gravity to determine urine concentrating ability in STIM1 ko mice versus wt mice. In mice fed NP or LP diet there was no difference in urinary specific gravity in STIM1 ko mice compared to wt mice (Fig. 2B ). When fed a HP diet STIM1 ko mice had significantly lower urinary specific gravity compared to wt mice. Based on above data we concluded that STIM1 ko mice have impaired urinary concentrating ability when challenged with HP diet.
Urine creatinine, urine urea, 24h urine urea, urine to plasma urea and fractional excretion of urea In STIM1 ko mice fed NP or LP diet urine creatinine was similar to wt mice fed NP or LP diet respectively (Fig. 3A) In STIM1 ko mice fed HP diet urine creatinine was significantly lower compared to wt mice fed HP diet (Fig. 3A) . In STIM1 ko mice fed NP or LP diet urine . Adult mice (4-10 weeks old) fed normal, low or high protein diet for one week were placed in metabolic cages for 24 h to collect urine. Columns represent averages ± standard errors of urine volume of wt and STIM1 ko mice fed normal, low or high protein diet. Statistical analysis was performed using a paired two-tailed Student's t test. (B) Specific urine gravity (ratio of urine/water). Columns represent averages ± standard errors of specific urine gravity compared to water of wt and STIM1 ko mice fed normal, low or high protein diet. Statistical analysis was performed using a paired two-tailed Student's t test.
urea was similar to wt mice fed NP or LP diet respectively (Fig. 3B) . When mice were fed HP diet urine urea increased 2 fold in both ko and wt mice, which was expected (Fig. 3B) . In STIM1 ko mice fed HP diet urine urea was significantly lower compared to wt mice fed HP diet (Fig. 3B ). These data (Fig. 3A and B ) support previous idea that STIM1 ko mice have impaired urinary concentrating ability when challenged with HP diet.
Next we asked whether STIM1 ko mice have impaired urea excretion. When we measured 24h urea excretion (4A), urine to plasma (U/P) urea (4B) and fractional excretion of urea (FEUr) (4C) we found no difference between STIM1 ko and wt mice fed either NP, LP or HP diet (Fig. 4A-C) . Twenty four hour urine urea and FEUr was much higher in ko and wt mice fed HP diet compared to mice fed NP or LP diet which was expected (Fig. 4A-C) . Urine to Plasma Urea (Ratio). Columns represent averages ± standard errors of 24 h urine to plasma urea of wt and STIM1 ko mice fed normal, low or high protein diet. Statistical analysis was performed using a paired two-tailed Student's t test. (C) Fractional Excretion of Urea (Ratio). Columns represent averages ± standard errors of fractional excretion of urea of wt and STIM1 ko mice fed normal, low or high protein diet. Statistical analysis was performed using a paired two-tailed Student's t test. 
Serum creatinine, BUN, albumin, CrCl and UrCl
To assess renal function we measured serum creatinine (Fig. 5A) and BUN (Fig. 5B ) and calculated CrCl (Fig. 6A) and UrCl (Fig. 6B) . In STIM1 ko mice serum creatinine, BUN, CrCl and UrCl wasn't significantly different compared to wt mice fed either NP, LP or HP diet ( Fig.  5 and 6 ). These data suggest that renal function was not impaired in STIM1 ko mice. When serum albumin was measured there was no significant difference between STIM1 ko and wt mice on either NP, LP or HP diet (Fig. 5C ).
Serum Ca, Urine Ca, FECa and 24h urinary calcium excretion
In STIM1 ko mice serum and urine calcium wasn't significantly different compared to wt mice fed either NP, LP or HP diet (Fig. 7A and B) . FECa and 24h urine calcium excretion in STIM1 ko mice wasn't significantly different compared to wt mice fed either NP or LP Ksp-cre mice are similar to wt mice based on serum markers such as creatinine, BUN, calcium and albumin and urinary markers such as calcium, creatinine, urea and specific gravity. In addition, creatinine clearance, urea clearance, fractional excretion of calcium and 24 hour calcium was similar in Stim1 fl/fl Ksp-cre mice compared to wt mice. This data indicate that STIM1 does not affect renal function.
Next, we decided to challenge Stim1 fl/fl Ksp-cre mice with low and high protein diet. High protein diet leads to increased urea production. Urea causes osmotic diuresis leading to water loss by the kidney. In compensation there will be increased reabsorption of free water in the collecting duct to prevent dehydration [26] . We showed that Stim1 fl/fl Ksp-cre mice fed low protein diet are similar to wt mice based on serum markers such as creatinine, BUN, calcium and albumin, urinary markers such as calcium, creatinine, urea and specific gravity and renal function markers such as creatinine clearance and urea clearance. Interestingly, Stim1 fl/fl Ksp-cre mice fed high protein diet had increased urine volume that was diluted based on urine specific gravity, urine creatinine and urine urea compared to wt mice. Hence Stim1 fl/ fl Ksp-cre mice have impaired ability to concentrate urine when challenged with high protein urine diet. On the other hand, 24 hour urinary urea excretion and fractional excretion of urea was similar in Stim1 fl/fl Ksp-cre and wt mice fed high protein diet indicating that STIM1 has no effect on urea transport.
We showed that renal function (based on serum creatinine, BUN, creatinine clearance and urea clearance) is similar in Stim1 fl/fl Ksp-cre and wt mice fed either low or high protein diet. This data indicate again that STIM1 does affect renal function even when mice are challenged with high protein diet that causes increased urine volume due to osmotic diuresis.
Since STIM1 plays a role in calcium signaling and homeostasis [27] , we measured calcium parameters. We showed that serum calcium, 24 hour urinary calcium excretion and fractional excretion of calcium was similar in Stim1 fl/fl Ksp-cre and wt mice fed either normal or low protein diet. Interestingly, Stim1 fl/fl Ksp-cre mice fed high protein diet had increased calcium excretion. In summary Stim1 fl/fl Ksp-cre mice challenged with high protein diet have increased urine volume due to impaired ability to concentrate urine and increased calcium excretion. It is not clear what leads to impaired ability to concentrate urine and increased calcium excretion and this will have to be explored in the future.
The role of STIM1 in V2R signaling is currently unknown. In addition to affecting the expression levels of AQP2 and V2R, STIM1 could affect AVP signaling either through 1) its control of SOCE or 2) through a direct effect of STIM1 on adenylyl cyclase activity. Studies have shown that AVP increases cAMP through two types of Ca 2+ -dependent adenylyl cyclase: AC6, which is inhibited by Ca 2+ and AC3, which is activated by calcium/calmodulin, [28, 29] . It is possible that both cyclases function together under certain physiological conditions [30] . AC6, expressed in the outer and inner medullary collecting ducts is inhibited by micromolar quantities of Ca
2+
. Prolonged exposure to AVP and the resultant increase in intracellular Ca 2+ would ultimately inhibit AC6 thus, dampening the cellular response to AVP. Thus, AC6's activity would dampened the response to prolonged AVP exposure. Hence, we speculate STIM1 could affect the functioning of Ca 2+ -dependent adenylyl cyclases by regulating SOCE. Alternately, STIM1 may have a direct effect on AC activity. Lifkimmiatis et al. [31] have shown that blocking the translocation of STIM1 to the plasma membrane reduces cAMP production [31] , implying a more direct action of STIM1 on AC activity.
A plausible hypothesis for impaired urinary concentration ability would be that levels of cAMP are reduced in Stim1 fl/fl Ksp-cre mice. Reduced cAMP levels will result in decreased insertion of AQP2 in collecting ducts. Decreased insertion of AQP2 would explain impaired urinary concentration ability in Stim1 fl/fl Ksp-cre mice.
Conclusion
The Stim1 fl/fl Ksp-cre mouse model will be useful to study molecular mechanisms of STIM1 and its role in the con-centrating mechanism in kidney.
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